European Pharmacopoeia -ph. Eur.- Monograph Tablets - -0478- !new!

| Test | Ph. Eur. Reference | When required | Common Pitfall | |------|--------------------|---------------|----------------| | Appearance | Visual inspection | Always | Overlooking color variation from batch to batch | | Identification A+B | As per monograph | Always | Using same HPLC condition for assay and ID (not allowed unless specified) | | Uniformity of mass | 2.9.5 | If active ≥ 50% w/w or ≥ 25 mg per unit | Not performing it on 20 tablets individually | | Uniformity of content | 2.9.6 | If active < 50% w/w or < 2 mg per unit | Applying mass method incorrectly to low-dose tablets | | Dissolution | 2.9.3 | Default for immediate-release | Using wrong apparatus (paddle vs basket) without justification | | Disintegration | 2.9.1 | Only if monograph permits | Forgetting time limit (e.g., 15 min for uncoated) | | Friability | 2.9.7 | Only if in specification | Testing hygroscopic tablets at ambient humidity |

Must produce a smooth, uniform suspension that passes through a 710 µm sieve after disintegration. 5. Storage, Packaging, and Labeling European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

Monograph 0478 defines tablets as solid pharmaceutical dosage forms containing a single dose of one or more active substances. They are generally obtained by compressing uniform volumes of particles or by other specialized manufacturing techniques like extrusion or molding. | Test | Ph

Months later, the updated Ph. Eur. publication carried the new language. Inspectors referenced it in audits; quality-control labs adjusted standard operating procedures; engineering teams tweaked dryer cycles and packaging protocols. A regional hospital pharmacist called Elena to thank the committee — a reduction in batch failures had improved stock reliability during a difficult influenza season. The change did not make headlines. It did not need to. Like many monographs, 0478 was a quiet force: technical, iterative, essential. Months later, the updated Ph